BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 616807)

  • 1. Isolation and preliminary characterization of drug resistant mutants of human lymphoblastoid cells.
    Duncan ME
    Cytobios; 1977; 19(73):45-66. PubMed ID: 616807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination.
    Gupta PK; Sahota A; Boyadjiev SA; Bye S; Shao C; O'Neill JP; Hunter TC; Albertini RJ; Stambrook PJ; Tischfield JA
    Cancer Res; 1997 Mar; 57(6):1188-93. PubMed ID: 9067291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion in expression of hypoxanthine-guanine phosphoribosyltransferase in 6-thioguanine resistant neuroblastoma: evidence for reduced enzyme levels associated with unaltered catalytic activity.
    Skaper SD; Spector EB; Seegmiller JE
    J Cell Physiol; 1977 Aug; 92(2):275-83. PubMed ID: 18484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations causing deficiency of APRT in fibroblasts cultured from human heterozygous for mutant APRT alleles.
    Steglich C; DeMars R
    Somatic Cell Genet; 1982 Jan; 8(1):115-41. PubMed ID: 7101101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutations of resistance to 2,6-diaminopurine and 6-methylpurine that affect adenine phosphoribosyltransferase in Escherichia coli K-12].
    Kocharian ShM; Chukanova TI; Sukhodolets VV
    Genetika; 1977; 13(10):1821-30. PubMed ID: 348574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous deficiency at autosomal locus aprt in human somatic cells in vivo induced by two different mechanisms.
    Hakoda M; Nishioka K; Kamatani N
    Cancer Res; 1990 Mar; 50(6):1738-41. PubMed ID: 2306728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of adenine salvage in mouse cell lines deficient in adenine phosphoribosyltransferase.
    Turker MS; Martin GM
    Mol Cell Biol; 1985 Oct; 5(10):2662-8. PubMed ID: 3837181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macrophage-mediated induction of drug-resistance variants in a mouse mammary tumor cell line].
    Yamashina K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):568-75. PubMed ID: 3758918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency nonrandom mutational event at the adenine phosphoribosyltransferase (aprt) locus of sib-selected CHO variants heterozygous for aprt.
    Bradley WE; Letovanec D
    Somatic Cell Genet; 1982 Jan; 8(1):51-66. PubMed ID: 7101104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity of Chinese hamster epithelial liver cells to toxic analogues of purines.
    Simili M; Tartaglia P; Turchi G
    Mutat Res; 1990 Jun; 244(2):157-61. PubMed ID: 2355938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hypoxanthine phosphoribosyltransferase deficiency in human U-937 cells.
    Radzun HJ; Parwaresch MR; Kreipe H
    J Natl Cancer Inst; 1986 Feb; 76(2):201-6. PubMed ID: 3456059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable alterations at the adenine phosphoribosyltransferase (APRT) locus in human lymphoblastoid cell lines.
    Amundson SA; Fortunato JE; Liber HL
    Mutat Res; 1992 Dec; 284(2):287-95. PubMed ID: 1281280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of mutants at the APRT locus in the L-5178Y TK+/TK- mouse lymphoma cell line.
    Paeratakul U; Taylor MW
    Mutat Res; 1986 Mar; 160(1):61-9. PubMed ID: 3951457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic cooperation in the selection of thioguanine-resistant mutants does not occur with the human B-lymphoblastoid cell TK6.
    Gundel RM; O'Neill JP
    Environ Mol Mutagen; 1997; 30(3):359-61. PubMed ID: 9366916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transformation in cell hybrids. I. Isolation and application of density-inhibited Balb/3T3 cells deficient in hypoxanthine phosphoribosyltransferase and resistant to ouabain.
    Jha KK; Ozer HL
    Somatic Cell Genet; 1976 May; 2(3):215-23. PubMed ID: 1028169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and preliminary characterisation of 6-thioguanine-resistant mutants of human diploid fibroblasts.
    Cox R; Masson WK
    Mutat Res; 1976 Jul; 36(1):93-104. PubMed ID: 950955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
    Yamashina K; Miller BE; Heppner GH
    Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of hypoxanthine-guanine phosphoribosyl transferase mutants of mouse L cells: evidence for mutations at different loci in the HGPRT gene.
    Wahl GM; Hughes SH; Capecchi MR
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):307-20. PubMed ID: 47331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate.
    Koyama H; Kodama H
    Cancer Res; 1982 Oct; 42(10):4210-4. PubMed ID: 7105014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for thioguanine-resistant human leukemia.
    Howell SB; Murphy MP; Johnson J; Wamsley P; Verma I
    Mol Biol Med; 1987 Jun; 4(3):157-68. PubMed ID: 3476817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.